Skip to main content
. 2021 Sep 22;4:1113. doi: 10.1038/s42003-021-02638-5

Fig. 7. Truncated JM#21 variants dose-dependently inhibit CXCL12 induced migration of cancer T cells.

Fig. 7

The migration of SupT1 cells towards a 100 ng/ml CXCL12 gradient in a transwell was tested in the presence of indicated concentrations of peptides. After 4 h amounts of migrated cells were determined by CellTiterGlo assay and normalized to values obtained for the PBS control. Shown are values derived from three individual experiments performed in triplicates ± SEM. ****p < 0.0001, **p < 0.01 (one-way ANOVA with Dunnett’s multiple comparison test, compared to PBS control).